Radiologix losses widen

Article

For the fourth quarter 2003, imaging services provider Radiologix reported service fee revenue of $66 million versus $64 million in the same period of the previous year, a 3.1% increase. But the company noted a net loss of $3 million for the quarter

For the fourth quarter 2003, imaging services provider Radiologix reported service fee revenue of $66 million versus $64 million in the same period of the previous year, a 3.1% increase. But the company noted a net loss of $3 million for the quarter compared with a net loss of $1.6 million for the fourth quarter 2002 and a loss from continuing operations of $1.3 million compared with a continuing operations loss of $585,000 in the fourth quarter of 2002. In fiscal year 2003, service-fee revenue fell 5.6% to $257 million from $272.2 million the previous year. The company incurred a net loss of $8 million for fiscal year 2003 compared with net income of $10.8 million for the year before. For fiscal year 2003, loss from continuing operations was $1.1 million, compared with income from continuing operations of $11.5 million for fiscal 2002.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.